These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24589563)

  • 1. S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population.
    Zawada AM; Rogacev KS; Hummel B; Berg JT; Friedrich A; Roth HJ; Obeid R; Geisel J; Fliser D; Heine GH
    Atherosclerosis; 2014 May; 234(1):17-22. PubMed ID: 24589563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
    Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
    Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children.
    Jabs K; Koury MJ; Dupont WD; Wagner C
    Metabolism; 2006 Feb; 55(2):252-7. PubMed ID: 16423634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Mild-to-Moderate Reduction in Glomerular Filtration Rate with Subclinical Atherosclerosis in Postmenopausal Women.
    Parv F; Beceanu A; Avram R; Timar RZ; Timar B; Gadalean F
    J Womens Health (Larchmt); 2017 Nov; 26(11):1201-1213. PubMed ID: 28537783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine Metabolites in Patients With Sepsis.
    Wexler O; Gough MS; Morgan MAM; Mack CM; Apostolakos MJ; Doolin KP; Mooney RA; Arning E; Bottiglieri T; Pietropaoli AP
    J Intensive Care Med; 2018 Jan; 33(1):37-47. PubMed ID: 27591199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine.
    Xiao J; You Y; Chen X; Tang Y; Chen Y; Liu Q; Liu Z; Ling W
    Front Nutr; 2022; 9():918698. PubMed ID: 36034911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase.
    Christopher SA; Melnyk S; James SJ; Kruger WD
    Mol Genet Metab; 2002 Apr; 75(4):335-43. PubMed ID: 12051965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2007 Dec; 28(12):1834-9. PubMed ID: 16996649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
    Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
    Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis.
    Zhang H; Liu Z; Ma S; Zhang H; Kong F; He Y; Yang X; Wang Y; Xu H; Yang A; Tian J; Zhang M; Cao J; Jiang Y; Guo X
    Mol Med Rep; 2016 Jul; 14(1):289-300. PubMed ID: 27175774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.
    Altintas E; Sezgin O
    Med Hypotheses; 2004; 63(5):834-7. PubMed ID: 15488656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
    Fu W; Dudman NP; Perry MA; Young K; Wang XL
    Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High bone concentrations of homocysteine are associated with altered bone morphology in humans.
    Holstein JH; Herrmann M; Splett C; Herrmann W; Garcia P; Histing T; Klein M; Kurz K; Siebel T; Pohlemann T; Menger MD
    Br J Nutr; 2011 Aug; 106(3):378-82. PubMed ID: 21521540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low S-adenosylmethionine/ S-adenosylhomocysteine Ratio in Urine is Associated with Chronic Kidney Disease.
    Kruglova MP; Grachev SV; Bulgakova PO; Ivanov AV; Virus ED; Nikiforova KA; Fedoseev AN; Savina GD; Kubatiev AA
    Lab Med; 2020 Jan; 51(1):80-85. PubMed ID: 31247080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?
    Loehrer FM; Angst CP; Brunner FP; Haefeli WE; Fowler B
    Nephrol Dial Transplant; 1998 Mar; 13(3):656-61. PubMed ID: 9550643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet.
    Poirier LA; Wise CK; Delongchamp RR; Sinha R
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):649-55. PubMed ID: 11401915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs.
    Yideng J; Jianzhong Z; Ying H; Juan S; Jinge Z; Shenglan W; Xiaoqun H; Shuren W
    DNA Cell Biol; 2007 Aug; 26(8):603-11. PubMed ID: 17688412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine.
    Kerins DM; Koury MJ; Capdevila A; Rana S; Wagner C
    Am J Clin Nutr; 2001 Dec; 74(6):723-9. PubMed ID: 11722952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.